Holen Sie sich die Stockscreener-App
1.24
0.00%
0.00
Handel nachbörslich:
1.25
0.01
+0.81%
Telomir Pharmaceuticals Inc Aktie (TELO) Neueste Nachrichten
Automated trading signals detected on Telomir Pharmaceuticals Inc.Breakout Watch & Verified Momentum Stock Alerts - Newser
How to forecast Telomir Pharmaceuticals Inc. trends using time seriesWeekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
Backtesting results for Telomir Pharmaceuticals Inc. trading strategiesStop Loss & Fast Gain Stock Trading Tips - Newser
What the charts say about Telomir Pharmaceuticals Inc. todayGold Moves & Fast Exit Strategy with Risk Control - Newser
Volume spikes in Telomir Pharmaceuticals Inc. stock – what they meanEarnings Recap Summary & Consistent Return Investment Signals - Newser
Telomir Pharmaceuticals Completes $2.9 Million Stock Sale - MSN
What high frequency data says about Telomir Pharmaceuticals Inc.July 2025 Decliners & Accurate Technical Buy Alerts - Newser
Is Telomir Pharmaceuticals Inc. a speculative investment2025 Key Lessons & Intraday High Probability Alerts - خودرو بانک
Returns Recap: Is Telomir Pharmaceuticals Inc. a cyclical or defensive stockQuarterly Earnings Report & AI Powered Trade Plan Recommendations - خودرو بانک
Telomir Pharmaceuticals Inc. stock volume spike explained2025 Market Overview & Technical Confirmation Alerts - Newser
Is Telomir Pharmaceuticals Inc. stock entering bullish territoryTrade Entry Summary & Stepwise Trade Execution Plans - Newser
What MACD and RSI say about Telomir Pharmaceuticals Inc.Earnings Growth Report & Consistent Profit Trading Strategies - Newser
Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathway - IndyStar
What drives Telomir Pharmaceuticals Inc.’s stock priceJuly 2025 Catalysts & Long-Term Safe Return Strategies - خودرو بانک
Volatility clustering patterns for Telomir Pharmaceuticals Inc.2025 Stock Rankings & Community Consensus Stock Picks - Newser
Using Python tools to backtest Telomir Pharmaceuticals Inc. strategiesJuly 2025 Patterns & Risk Controlled Daily Plans - Newser
Telomir Pharmaceuticals raises $2.9 million through at-the-market stock sale - Investing.com Canada
Telomir Pharmaceuticals raises $2.9 million through at-the-market stock sale By Investing.com - Investing.com South Africa
Real time social sentiment graph for Telomir Pharmaceuticals Inc.Quarterly Profit Review & Proven Capital Preservation Tips - Newser
Earnings visualization tools for Telomir Pharmaceuticals Inc.Portfolio Value Summary & AI Forecasted Stock Moves - Newser
Is Telomir Pharmaceuticals Inc.’s ROE strong enoughRate Cut & Step-by-Step Swing Trade Plans - خودرو بانک
Can swing trading help recover from Telomir Pharmaceuticals Inc. lossesIPO Watch & Target Return Focused Picks - Newser
Is Telomir Pharmaceuticals Inc. stock a hidden gemMarket Sentiment Summary & Capital Protection Trade Alerts - خودرو بانک
Using economic indicators to assess Telomir Pharmaceuticals Inc. potentialEarnings Summary Report & Breakout Confirmation Trade Signals - Newser
Is this a good reentry point in Telomir Pharmaceuticals Inc.Weekly Profit Recap & AI Driven Price Predictions - Newser
How to track smart money flows in Telomir Pharmaceuticals Inc.2025 Market Overview & Reliable Volume Spike Alerts - Newser
How hedge fund analytics apply to Telomir Pharmaceuticals Inc. stockBuy Signal & Stock Portfolio Risk Management - Newser
Is Telomir Pharmaceuticals Inc. building a consolidation base2025 Top Gainers & Consistent Profit Alerts - Newser
Should you avoid Telomir Pharmaceuticals Inc. stock right now2025 Stock Rankings & Risk Managed Investment Signals - خودرو بانک
Using fundamentals and technicals on Telomir Pharmaceuticals Inc.Gap Down & Free High Accuracy Swing Entry Alerts - Newser
Is Telomir Pharmaceuticals Inc. forming a bottoming baseGap Down & Weekly High Return Forecasts - Newser
Is now a turning point for Telomir Pharmaceuticals Inc.2025 Price Targets & Free Verified High Yield Trade Plans - Newser
Combining machine learning predictions for Conduit Pharmaceuticals Inc.Weekly Stock Report & Real-Time Sentiment Analysis - Newser
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):